Mycophenolate Mofetil Inhibits Interleukin-6 Secretion in Human Endothelial Cells

黄燕飞,刘志红,黄海东,黎磊石
DOI: https://doi.org/10.3969/j.issn.1006-298x.2003.01.004
2003-01-01
Abstract:Objective:To investigate the effect of mycophenolate mofetil (MMF) on interleukin-6 (IL-6) secretion in human endothelial cells.A human umbilical vein endothelial cell line (HUVEC) from ATCC was used, and the effect of mycophenolic acid (MPA), active metabolite of MMF, was observed in the study. HUVEC were treated with TNFα or TNFα+MPA or TNFα+MPA+guanosine for 24 hours. The secretion of IL-6 was measured with enzyme linked immunosorbent assay (ELISA).TNFα(10 ng/L) significantly increased IL-6 secretion in HUVEC [ 11 485 ±521 3 vs 1 291 7 ±108 6 ng/(L·10 6 cell), P 0.01], and this effect was attenuated by MPA (10 or 50 μmol/L) in a dose-dependent manner. Addition of guanosine had no effect on IL-6 secretion inhibited by MPA [ 4 254 0 ±672 8 vs 3 747 3 ±821.8 ng/(L·10 6 cell), P 0.05], indicating that inhibition of purine synthesis is not responsible for reduced IL-6 secretion. MMF inhibits IL-6 secretion induced by TNFα in human endothelial cells, and this effect may be associated with MMF's therapeutic effects in vasculitis and inflammatory diseases.
What problem does this paper attempt to address?